BioXcel Therapeutics (BTAI) Assets Average (2018 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Assets Average of $39.5 million for Q1 2026, up 2.65% year-over-year from $38.5 million in Q1 2025, and down 12.0% quarter-over-quarter from $44.9 million in Q4 2025.
BioXcel Therapeutics (BTAI) Assets Average (2018 - 2026) Analysis & Trends
BioXcel Therapeutics' Assets Average history runs 9 years deep, the most recent figure standing at $39.5 million for Q1 2026.
- In Q1 2026, Assets Average rose 2.65% year-over-year to $39.5 million; the TTM figure through Mar 2026 stood at $39.5 million (up 2.65% YoY), while the FY2025 annual figure was $41.6 million, down 25.69% from the prior year.
- Assets Average for Q1 2026 stood at $39.5 million, down from $44.9 million in the prior quarter.
- The five-year high for Assets Average was $246.5 million in Q3 2022, with the low at $32.2 million in Q2 2025.
- The 5-year median for Assets Average is $78.0 million (2024), against an average of $113.5 million.
- The sharpest annual moves came in 2022 and 2023: Assets Average advanced 7.18% in 2022, then slumped 61.36% in 2023.
- BioXcel Therapeutics' Assets Average stood at $225.3 million in 2022, then plunged by 61.36% to $87.1 million in 2023, then slumped by 49.91% to $43.6 million in 2024, then grew by 2.84% to $44.9 million in 2025, then decreased by 12.0% to $39.5 million in 2026.
- Business Quant data shows BTAI's Assets Average at $39.5 million in Q1 2026, $44.9 million in Q4 2025, and $35.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 5.97 Bn |
| 10 | BioXcel Therapeutics | 24.25 Mn | 24.25 Mn | 160,000.00 | 31.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.41 Mn |
| Mar 31, 2026 | 39.47 Mn |
| Dec 31, 2025 | 44.85 Mn |
| Sep 30, 2025 | 35.29 Mn |
| Jun 30, 2025 | 32.18 Mn |
| Mar 31, 2025 | 38.45 Mn |
| Dec 31, 2024 | 43.62 Mn |
| Sep 30, 2024 | 57.16 Mn |
| Jun 30, 2024 | 73.88 Mn |
| Mar 31, 2024 | 78.01 Mn |
| Dec 31, 2023 | 87.08 Mn |
| Sep 30, 2023 | 120.27 Mn |
| Jun 30, 2023 | 160.10 Mn |
| Mar 31, 2023 | 192.98 Mn |
| Dec 31, 2022 | 225.34 Mn |
| Sep 30, 2022 | 246.53 Mn |
| Jun 30, 2022 | 229.64 Mn |
| Mar 31, 2022 | 225.24 Mn |
| Dec 31, 2021 | 250.39 Mn |
| Sep 30, 2021 | 271.22 Mn |